SOLB Solvay SA

Participation notification by UBS Group AG

Participation notification by UBS Group AG

Brussels, April 29, 2024, 08:30 CEST - Regulated information

In line with Belgian transparency legislation (Law of May 2, 2007), UBS Group AG recently sent to Solvay the following transparency notification indicating that they crossed the threshold of 5%. 

The notification, dated April 23, 2024, contains the following information:

  • Reason for the notification: acquisition or disposal of financial instruments that are treated as voting securities. 
  • Notified by: A parent undertaking or a controlling person
  • Date on which the threshold is crossed: April 17, 2024
  • Threshold of direct voting rights crossed: 5% upwards
  • Denominator: 105,876,416 
  • Additional information: The disclosure obligation arose due to the total indirect holdings of UBS Group AG in voting rights of Solvay SA, held directly by controlled undertakings, going above 5% on 17th April 2024. This was caused by an increase in the Trading Book holdings of the aforementioned entities above 5% and therefore no longer being exempt from reporting.
  • Persons subject to the notification requirement: UBS Group AG (Bahnhofstrasse 45, 8001 Zürich).



 

Attachments



EN
29/04/2024

Underlying

SOLBSolvay SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Solvay SA

Hilde Van Boxstael ... (+8)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Kristof Samoy
  • Michiel Declercq
  • Sharad Kumar S.P
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi
BEKB BEKAERT SA
GBLB Groupe Bruxelle... ... (+8)

Morning Notes : ABI BB, AD NA, BEKB BB, EURN BB, GBLB BB, MONT BB, SOL...

: ABI BB, AD NA, BEKB BB, EURN BB, GBLB BB, MONT BB, SOLB BB, MAAT FP

BEKB BEKAERT SA
GBLB GROUPE BRUXELLES LAMBERT SA
EURN EURONAV NV
SOLB SOLVAY SA
MONT MONTEA SCA
ABI ANHEUSER-BUSCH INBEV SA/NV
AD KONINKLIJKE AHOLD DELHAIZE N.V.
MAAT MAAT PHARMA SA
05/08/24 May 8, 2024 1 EN
Wim Hoste
  • Wim Hoste
SOLB SOLVAY SA

Solvay Model update post 1Q, reconfirming our BUY rating

We upped our FY24 adjusted EBITDA forecast by 2% following the better than expected 1Q24 results. After the recent spun off of Syensqo, Solvay is a base chemicals group with leading market and technology positions in the vast majority of its businesses. The company will be managed with a conservative financial approach, favouring dividends over aggressive growth and operating with a solid balance sheet (1.4x leverage). The stable to growing dividend flow implies a solid 7% dividend yield. Other ...

05/08/24 May 8, 2024 1 EN
Wim Hoste
  • Wim Hoste
SOLB SOLVAY SA

Solvay Conference call feedback

Below are the highlights from the conference call. 1Q underlying EBITDA dropped by 13.6% organically to 265m which was 13% better than our forecast and 12% above CSS. Solvay reiterated its FY uEBITDA guidance which calls for a 10-20% organic decline vs the restated 2023 base. After the recent spun off of Syensqo, Solvay is a base chemicals group with leading market and technology positions in the vast majority of its businesses. The company will be managed with a conservative financial approach...

05/07/24 May 7, 2024 1 EN
Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri
INFINEON INFINEON TECHNOLOGIES AG
FME FRESENIUS MEDICAL CARE AG & CO. KGAA
RCO REMY COINTREAU SA
LONN LONZA GROUP AG
EN BOUYGUES SA
ADEN ADECCO GROUP AG
SCR SCOR SE
ZAL ZALANDO SE
GEBN GEBERIT AG
HEI HEIDELBERGCEMENT AG
SOLB SOLVAY SA
COLO B COLOPLAST A/S CLASS B
BP. BP P.L.C.
SHL SIEMENS HEALTHINEERS AG
UN0 UNIPER SE
05/07/24 May 7, 2024 1 EN
Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri
V1S ARKEMA
INFINEON INFINEON TECHNOLOGIES AG
FME FRESENIUS MEDICAL CARE AG & CO. KGAA
RCO REMY COINTREAU SA
LONN LONZA GROUP AG
EN BOUYGUES SA
ADEN ADECCO GROUP AG
SCR SCOR SE
ZAL ZALANDO SE
GEBN GEBERIT AG
HEI HEIDELBERGCEMENT AG
SOLB SOLVAY SA
COLO B COLOPLAST A/S CLASS B
BP. BP P.L.C.
SHL SIEMENS HEALTHINEERS AG
UN0 UNIPER SE
05/07/24 May 7, 2024 1 FR

ResearchPool Subscriptions

Get the most out of your insights

Get in touch